MidTECH - NHS Innovations; Dr Barry Sturman-Mole, Chief Executive of MidTECH, Outlines the Expert Intellectual Property (IP) and Innovation Commercialisation Support the Company Provides to the NHS, from the New SHA Clusters through Hospital Trusts to GP Consortia

The Birmingham Post (England), September 22, 2011 | Go to article overview
Save to active project

MidTECH - NHS Innovations; Dr Barry Sturman-Mole, Chief Executive of MidTECH, Outlines the Expert Intellectual Property (IP) and Innovation Commercialisation Support the Company Provides to the NHS, from the New SHA Clusters through Hospital Trusts to GP Consortia


Byline: Dr Barry Sturman-Mole

The ability of NHS organisations, teams and individuals to innovate - to adopt new ideas to meet new challenges - is crucial to the task of responding to the changing needs of patients and to the need to attract and retain employees. The NHS is the origin of many new ideas, not only from its dedicated Research & Development capability but also from frontline staff who develop solutions to meet current challenges. In certain cases those ideas may contain valuable intellectual property (IP) and lead to commercial solutions that may generate income or lead to cost-savings.

As an NHS innovation 'hub', MidTECH's primary function is to provide NHS Clusters, Trusts and Consortia with the expert assistance needed to assess and commercialise innovations and IP which arise from the ideas and activities of individuals within those organisations. MidTECH is an intellectual property (IP) and technology commercialisation management company, with an established record of guiding NHS innovations through from concept to market. After receiving an initial idea, we assess its feasibility and market potential, take appropriate steps to protect any IP, develop 'proof of concept demonstrations' and prototypes where appropriate, identify potential industrial partners and negotiate the legal agreements - always ensuring that the profits and benefits accrue to the inventor, the trust, the NHS and its patients.

MidTECH has assessed more than 600 ideas, and concluded more than 60 intellectual property commercialisation agreements (licences, joint ventures and spin outs) on behalf of the NHS. The NHS benefits from our cost-effective innovation management and exploitation services and we assist NHS employees with a broad spectrum of innovations. These range from medical devices and technologies to software and training materials.

In addition to its innovation management services, MidTECH also provides: Advice to NHS management teams on internal IP policy, process, strategy and associated implementation IP workshops and surgeries Market research IP Diligence for contractual purposes Bespoke IP tools and expertise to help identify opportunities and threats Advice and assistance on purchasing R&D services from third parties/subcontractors Access to and advice on funding Access to an exclusive helpline for project management and IP-related queries Examples of recent projects MidTECH, on behalf of the Dudley Group of Hospitals, has worked with Birmingham University, through its technology transfer arm Alta Innovations, on a new therapeutic system.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

MidTECH - NHS Innovations; Dr Barry Sturman-Mole, Chief Executive of MidTECH, Outlines the Expert Intellectual Property (IP) and Innovation Commercialisation Support the Company Provides to the NHS, from the New SHA Clusters through Hospital Trusts to GP Consortia
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?